Chiara Napoletano Selected Research

Chiara Napoletano Research Topics

Disease

30	Neoplasms (Cancer) 06/2022 - 07/2007
8	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 12/2010
5	Breast Neoplasms (Breast Cancer) 05/2022 - 09/2010
3	Cholangiocarcinoma 01/2021 - 06/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2018
3	Carcinoma (Carcinomatosis) 10/2020 - 01/2003
3	Ascites 01/2017 - 12/2010
2	Vulvar Neoplasms (Vulvar Cancer) 10/2016 - 11/2007
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2011 - 01/2008
2	Testicular Neoplasms (Testicular Cancer) 01/2008 - 11/2007
1	Glioblastoma (Glioblastoma Multiforme) 06/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	medullary Thyroid cancer 01/2021
1	Carcinogenesis 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Ovarian Epithelial Carcinoma 10/2020
1	Inflammation (Inflammations) 09/2020
1	Infections 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2014
1	Fibrosis (Cirrhosis) 12/2014
1	Liver Diseases (Liver Disease) 12/2014
1	Disease Progression 08/2012
1	Endometrioid Carcinoma 07/2009
1	Melanoma (Melanoma, Malignant) 11/2007
1	Lymphatic Metastasis 11/2007

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2017 - 09/2007
6	Proteins (Proteins, Gene)FDA Link 07/2021 - 02/2008
5	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2016
4	Polysaccharides (Glycans)IBA 06/2022 - 09/2007
4	Galactose (Galactopyranose)FDA LinkGeneric 10/2020 - 09/2007
4	Immune Checkpoint InhibitorsIBA 09/2020 - 01/2017
3	LectinsIBA 06/2022 - 04/2012
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	C-Type Lectins (C-Type Lectin)IBA 10/2020 - 09/2007
3	Glycoproteins (Glycoprotein)IBA 10/2020 - 02/2014
3	Bevacizumab (Avastin)FDA Link 03/2019 - 12/2010
3	Biological ProductsIBA 01/2018 - 07/2012
3	MucinsIBA 01/2017 - 09/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2020 - 01/2018
2	Cancer VaccinesIBA 01/2018 - 04/2014
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2017 - 02/2008
2	ParaffinIBA 10/2016 - 11/2007
2	AC133 AntigenIBA 10/2016 - 07/2009
2	Peptides (Polypeptides)IBA 04/2016 - 12/2011
2	CarbohydratesIBA 01/2015 - 02/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2012 - 07/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012 - 01/2011
2	Monoclonal AntibodiesIBA 01/2011 - 01/2011
1	LigandsIBA 06/2022
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2021
1	cabozantinibIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	SugarsIBA 10/2020
1	Vicia lectinsIBA 10/2020
1	ChemokinesIBA 09/2020
1	CytokinesIBA 09/2020
1	AldehydesIBA 01/2018
1	VaccinesIBA 01/2018
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 10/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2016
1	Carcinoembryonic AntigenIBA 04/2016
1	Monatide (IMS 3015)IBA 04/2016
1	dactolisibIBA 01/2015
1	Albumin-Bound Paclitaxel FDA Link 01/2015
1	AutoantigensIBA 01/2015
1	Tumor Biomarkers (Tumor Markers)IBA 04/2014
1	Carboplatin (JM8)FDA LinkGeneric 08/2012
1	GlycopeptidesIBA 04/2012
1	AcetylgalactosamineIBA 04/2012
1	EpitopesIBA 12/2011
1	Immunoglobulin G (IgG)IBA 12/2011
1	Complementary DNA (cDNA)IBA 12/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2011
1	AntibodiesIBA 01/2011
1	Epithelial Cell Adhesion MoleculeIBA 01/2011
1	Trastuzumab (Herceptin)FDA Link 01/2011
1	farletuzumabIBA 01/2011
1	human ERBB2 proteinIBA 01/2011
1	oregovomabIBA 01/2011
1	Cisplatin (Platino)FDA LinkGeneric 07/2009
1	Interleukin-8 (Interleukin 8)IBA 07/2009
1	Metalloproteases (Metalloproteinases)IBA 07/2009
1	Hepatitis B e AntigensIBA 11/2007
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2003

Therapy/Procedure

10	Therapeutics 05/2022 - 01/2011
9	Immunotherapy 05/2022 - 07/2007
4	Drug Therapy (Chemotherapy) 03/2019 - 01/2008
3	Neoadjuvant Therapy 08/2012 - 01/2008
1	Immunomodulation 05/2022
1	Transplantation 12/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2014
1	Hysterectomy 01/2008